Lexicon Pharmaceuticals I...

0.46
-0.00 (-0.17%)
At close: Apr 01, 2025, 3:59 PM
0.46
0.08%
After-hours: Apr 01, 2025, 07:59 PM EDT

Lexicon Pharmaceuticals Statistics

Share Statistics

Lexicon Pharmaceuticals has 361.49M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 361.49M
Shares Change (YoY) 0%
Shares Change (QoQ) 0%
Owned by Institutions (%) 82.34%
Shares Floating 179.54M
Failed to Deliver (FTD) Shares 8.39K
FTD / Avg. Volume 0.06%

Short Selling Information

The latest short interest is 39.1M, so 10.82% of the outstanding shares have been sold short.

Short Interest 39.1M
Short % of Shares Out 10.82%
Short % of Float 23.18%
Short Ratio (days to cover) 7.4

Valuation Ratios

The PE ratio is undefined and the forward PE ratio is -1.86. Lexicon Pharmaceuticals's PEG ratio is undefined.

PE Ratio undefined
Forward PE -1.86
PS Ratio 7.6
Forward PS 0.9
PB Ratio 1.62
P/FCF Ratio undefined
PEG Ratio undefined
Financial Ratio History

Enterprise Valuation

Lexicon Pharmaceuticals Inc. has an Enterprise Value (EV) of 421.93M.

EV / Earnings -2.11
EV / Sales 13.58
EV / EBITDA -2.29
EV / EBIT -2.14
EV / FCF -2.35

Financial Position

The company has a current ratio of 5.44, with a Debt / Equity ratio of undefined.

Current Ratio 5.44
Quick Ratio 5.44
Debt / Equity undefined
Total Debt / Capitalization 42.62
Cash Flow / Debt -1.65
Interest Coverage undefined

Financial Efficiency

Return on equity (ROE) is -1.37% and return on capital (ROIC) is -77.5%.

Return on Equity (ROE) -1.37%
Return on Assets (ROA) -0.67%
Return on Capital (ROIC) -77.5%
Revenue Per Employee $301,757.28
Profits Per Employee $-1,945,660.19
Employee Count 103
Asset Turnover 0.1
Inventory Turnover 2.67

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -79.82% in the last 52 weeks. The beta is 1.05, so Lexicon Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.05
52-Week Price Change -79.82%
50-Day Moving Average 0.6
200-Day Moving Average 1.25
Relative Strength Index (RSI) 50.15
Average Volume (20 Days) 13.2M

Income Statement

In the last 12 months, Lexicon Pharmaceuticals had revenue of 31.08M and earned -200.4M in profits. Earnings per share was -0.63.

Revenue 31.08M
Gross Profit 30.46M
Operating Income -197.12M
Net Income -200.4M
EBITDA -184.29M
EBIT -197.12M
Earnings Per Share (EPS) -0.63
Full Income Statement

Balance Sheet

The company has 66.66M in cash and 108.4M in debt, giving a net cash position of -41.74M.

Cash & Cash Equivalents 66.66M
Total Debt 108.4M
Net Cash -41.74M
Retained Earnings -1.97B
Total Assets 298.42M
Working Capital 200.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -178.78M and capital expenditures -1.03M, giving a free cash flow of -179.81M.

Operating Cash Flow -178.78M
Capital Expenditures -1.03M
Free Cash Flow -179.81M
FCF Per Share -0.56
Full Cash Flow Statement

Margins

Gross margin is 98.02%, with operating and profit margins of -634.2% and -644.78%.

Gross Margin 98.02%
Operating Margin -634.2%
Pretax Margin -644.78%
Profit Margin -644.78%
EBITDA Margin -592.93%
EBIT Margin -634.2%
FCF Margin -578.52%

Dividends & Yields

LXRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -136.96%
FCF Yield -107.46%
Dividend Details

Analyst Forecast

The average price target for LXRX is $4, which is 769.6% higher than the current price. The consensus rating is "Hold".

Price Target $4
Price Target Difference 769.6%
Analyst Consensus Hold
Analyst Count 4
Stock Forecasts

Stock Splits

The last stock split was on May 21, 2015. It was a backward split with a ratio of 1:7.

Last Split Date May 21, 2015
Split Type backward
Split Ratio 1:7

Scores

Altman Z-Score -9.88
Piotroski F-Score 3